(Q35625041)

9 August 2017

1 reference

title

Empirically derived live-attenuated vaccines against dengue and Japanese encephalitis (English)

1 reference

Japanese encephalitis virus

9 August 2017

main subject

0 references

0 references

1 reference

1 reference

Jean-François Saluzzo

series ordinal

1

1 reference

9 August 2017

publication date

1 January 2003

1 reference

Advances in Virus Research

9 August 2017

published in

1 reference

9 August 2017

volume

61

1 reference

9 August 2017

page(s)

419-443

1 reference

Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Experimental studies on dengue. I. Isolation, identification and modification of the virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Sequential immunization as a vaccination procedure against dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Research on dengue during World War II

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Dengue in the early febrile phase: viremia and antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2803%2961011-0

7 January 2021

10.1016/S0065-3527(03)61011-0

Identifiers

DOI

1 reference

9 August 2017

1 reference